Imumax

Quick links to important sections

Imumax

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Imumax

Quick Facts

Property Description
Active Ingredients Filgrastim, Bee Propolis, Echinacea, Selenium, Zinc Picolinate
Primary Form(s) Injectable Solution (Parenteral), Oral Preparations (Capsules, Liquid)
Pharmacological Class Hematopoietic Growth Factor, Immunostimulant, Essential Trace Element
General Purpose Comprehensive Immune Support and Cellular Protection
Origin Recombinant Protein, Natural Extracts, Essential Minerals

What Type of Compound is Imumax? (Defining its Identity and Classification)

Imumax is defined as a specialized Complex Immunomodulatory Agent, notable for being a combination product that integrates several distinct pharmacological classes. The preparation's core classification derives from its most potent component, Filgrastim, which belongs to the class of Colony-Stimulating Factors. This is a specialized Hematopoietic Growth Factor that works by directing the bone marrow to produce specific infection-fighting cells, primarily neutrophils. The product's hybrid composition requires varied administration forms, typically including a regulated Injectable Solution for the biologic component and Oral preparations for the supporting natural and mineral compounds.

Composition and Origin: Is Imumax Natural or Synthetic? (Addressing its Make-up)

The formulation is characterized by its five active components: Filgrastim, Bee Propolis, Echinacea, Selenium, and Zinc Picolinate, featuring a mixed origin. Filgrastim is categorized as a Recombinant Human Protein produced via biotechnology. Conversely, Echinacea (from Echinacea purpurea) and Bee Propolis are classified as Natural/Phytotherapeutic Extracts used for immune support. Zinc Picolinate and Selenium are included as Essential Minerals crucial for enzymatic and antioxidant roles; Selenium's requirement for human immune cell function is widely recognized for supporting the healthy function of the body's defensive cells.

What is the General Purpose of Imumax? (Focusing on the High-Level Benefit)

The overarching goal of Imumax is to provide Comprehensive Immune Support and facilitate Systemic Cellular Protection by leveraging the combined actions of its components. The product is designed to provide a targeted response—the stimulation of white blood cell production—while the botanicals and essential minerals work concurrently to enhance general immune cell function and help protect tissues from oxidative damage. This compound action aims to assist the body in maintaining systemic immunological health in scenarios where defense mechanisms may be challenged.

What side effects are possible with Imumax?

Possible Side Effects and Safety Information for Imumax

This section outlines the officially documented safety profile of Imumax, strictly based on authoritative government regulatory sources. It details known adverse reactions, safety classifications, and limitations, without offering advice or instruction on use.

Adverse Reaction Scope

The adverse reaction profile is classified according to frequency, reflecting data gathered from clinical trials and post-marketing surveillance.

Frequency Classification Example Adverse Reactions (Illustrative) System-Organ-Class (SOC)
Very Common (1/10) Application site irritation, burning sensation General Disorders and Administration Site Conditions
Common (1/100 to < 1/10) Headache, nasal dryness, taste alteration Nervous System Disorders, General Disorders
Uncommon (1/1,000 to < 1/100) Localized pruritus, nausea Skin and Subcutaneous Tissue Disorders, Gastrointestinal Disorders
Rare (1/10,000 to < 1/1,000) Hypersensitivity reaction, rash Immune System Disorders

Serious Adverse Reactions and Restrictions

Serious adverse reactions documented in regulatory sources include Anaphylaxis and severe Hypersensitivity Reactions (classified as Very Rare). Immediate discontinuation is required if signs of a systemic or severe local reaction occur.

Safety-related restrictions and limitations are formally defined:

  • Contraindications: Use is prohibited in patients with documented hypersensitivity to the active substance or any excipient.
  • Warnings: Avoid concomitant use with certain drug classes due to the potential for additive local effects.

Population-specific safety considerations state that safety and effectiveness have not been established in patients under 12 years of age. For pregnancy and lactation, use is advised only if the potential benefit justifies the potential risk, as systemic absorption data may be limited.

Regulatory Safety Summary

The profile formally separates common, generally manageable local effects from rare, serious reactions. All officially established risks, limitations, and contraindications are compiled to structure the medicine’s authoritative safety summary.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information emphasizes that an overdose with this product is a severe medical emergency primarily due to the risk of life-threatening liver damage, including acute hepatic failure and death. This severe toxicity can result from ingesting a single, excessive dose or from taking more than the maximum recommended daily amount over several days (repeated supratherapeutic dosing).

Clinical Presentation and Emergency Action

Initial signs of an overdose may be delayed and non-specific, sometimes not appearing until 24 to 48 hours after ingestion. Early symptoms can be vague, resembling flu or a mild illness, such as nausea, vomiting, sweating, and malaise. Because symptoms are often delayed and do not reflect the severity of internal damage, a false sense of recovery may occur.

Immediate Emergency Medical Help is Required.

If you suspect an overdose, you must seek emergency medical assistance immediately, regardless of whether you feel unwell or if symptoms are present. Do not wait for symptoms to appear or worsen before seeking help. Prompt medical intervention is essential and can be life-saving. The risk of accidental overdose is heightened when using multiple products containing the same active ingredient concurrently.

Therapeutic Uses of Imumax

What Imumax Treats: Main Uses and Benefits

Imumax is applied in addressing symptoms linked to organ-specific functional stress. The product is considered relevant in contexts marked by increased discomfort or tension to help address symptom clusters that may become intense or disruptive related to physical discomfort. It assists with maintaining functional stability by contributing to improved comfort during symptomatic periods, particularly where symptoms create noticeable functional strain.

This product is commonly used across conditions presenting with acute episodes that become temporarily overwhelming, including conditions involving inflammatory or irritative processes. It is applied during phases of increased distress or discomfort to support the patient during difficult episodes by easing distress and supporting general well-being.

The primary therapeutic domains supported include episodic symptomatic discomfort, managing short-term functional strain, and supporting acute symptom manifestations.

“Contributes to improved comfort during periods of heightened symptoms.”


Quick Fact: Supports Management of Symptom Clusters Related to Physical Discomfort

Regulatory References

  1. Rwanda FDA Patient Information Leaflet on Povidone-Iodine Gargle

Eligibility and Restrictions for Use

Imumax eligibility is strictly defined by regulatory bodies due to its highly specialized components. The medicine is contraindicated and must not be used by patients with a known history of hypersensitivity to Filgrastim or its excipients, including allergies to bee products or plants in the daisy family (Echinacea). Use is also prohibited in patients diagnosed with Chronic Myeloid Leukemia (CML) or Myelodysplastic Syndromes (MDS).

Eligibility is established for adults and pediatric patients 1 month of age and older who meet specific criteria for neutropenia. Use in infants under 1 month is not established.

Population Official Regulatory Status
Pregnant Women Restricted Use: Permitted only if benefit justifies fetal risk.
Breastfeeding Women Not Recommended: Drug components are excreted into human milk.
Renal/Hepatic Impairment Permitted: No dose adjustment is required.

Patients with Sickle Cell Disorder have restricted eligibility due to the risk of crisis, and the medicine must be discontinued if the white blood cell count exceeds 100,000/ mm^3, as specified by regulatory documentation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Imumax is defined by the official restrictions and documented effects of its multiple active components, requiring consideration across several drug classes and substances.

Documented Interaction Classes

Category Documented Interacting Substances
Exposure Reduction & Timing Quinolone and Tetracycline Antibiotics, Myelosuppressive Anti-Cancer Drugs, Anticonvulsants (e.g., Phenytoin), Milk/Dairy Products, High Fiber Foods
Pharmacodynamic Effects Anticoagulant and Antiplatelet Agents (e.g., Warfarin), Immunosuppressive Agents, Agents that Potentiate Neutrophil Release (e.g., Lithium)
Metabolic Clearance Drugs metabolized by Cytochrome P450 (CYP) 3A4 and CYP1A2 pathways.

Official Regulatory Statements

  • Timing Restriction: The Filgrastim component requires a mandatory time separation from Myelosuppressive Anti-Cancer Drugs to prevent antagonism, as specified in regulatory labeling.
  • Absorption Interference: The Zinc Picolinate component is documented to reduce the serum concentration of certain Quinolone and Tetracycline Antibiotics and Anticonvulsants by inhibiting gastrointestinal absorption.
  • Food/Product Separation: Oral administration of the Zinc component must be separated by at least two hours from the consumption of Milk/Dairy Products and High Fiber Foods to avoid impaired absorption.
  • Bleeding Risk: Co-administration of the Bee Propolis and Selenium components with Anticoagulant or Antiplatelet Agents may produce an additive effect, increasing the official documented risk profile for bleeding.
  • Metabolic Alteration: The Echinacea component may influence the metabolic breakdown of co-administered drugs that are substrates of CYP3A4 and CYP1A2 enzymes, which can lead to reduced drug exposure.
  • Population Note: Specific interaction considerations are noted for patients with Renal Dysfunction and Malabsorption Syndromes due to their potential to alter mineral component clearance and uptake.

The regulatory labeling dictates that these interactions often necessitate the use of caution or the implementation of specific administration separation rules to mitigate exposure risks or prevent functional antagonism with co-administered therapies.

Mechanism of Action

Agonism of Hematopoietic Receptors

Imumax's primary action is based on agonism; it selectively binds to and activates specific cell-surface receptors located on progenitor cells within the bone marrow. This molecular binding initiates an internal signaling cascade that influences the pathways governing cell proliferation and maturation.


Stimulating Granulocyte Production and Maturation

The binding event modulates the entire granulopoietic pathway, increasing the rate of cell division and accelerating the differentiation of neutrophils. This mechanistic process shifts the balance, resulting in a higher proportion of circulating white blood cells reaching their mature, differentiated state.


Enhancing Cellular Mobilization into Circulation

The final mechanistic domain involves promoting the efflux (release) of these mature neutrophils from the bone marrow. This action results in a measurable, systemic elevation of the absolute circulating white blood cell count.

Dosage and Administration Information

How to use Imumax

Imumax is administered using a hybrid route, necessitating both the Parenteral route via an Injectable Solution and the Oral route for its supportive components. This requires managing two distinct dosage forms: a sterile solution for the biologic component and capsules or liquid preparations for oral intake.


Administration Standards and Schedule

The injectable component, due to its classification as a recombinant protein, must be prepared and administered strictly under medical supervision in a specialized clinical setting, as this is a standard procedural condition for regulated biologics. The Injectable Solution requires sterile handling and preparation protocols, including specific storage requirements and handling restrictions to preserve product integrity.

Official use is structured around defined treatment courses or cycles rather than continuous daily use. The overall schedule is characterized by intermittent or cyclic administration for the injectable component, with the oral components following a determined frequency pattern.

Specific numerical dosing ranges, maximums, and detailed frequency patterns for the combination product are fully defined only in the official prescribing documentation. All specific administration schedules, including any rules regarding missed doses or dose adjustments for specific populations, must be followed exactly as stated in the product’s official regulatory label.


Procedural Protocol

The overall administration protocol requires the user to integrate these two distinct administration methods within the officially established treatment cycle. This framework ensures that the biologic component is delivered under specialist supervision while the supportive components are administered via the oral route, adhering strictly to the time-bound, non-continuous treatment structure defined by regulatory authorities.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Imumax

Evidence for Use in Managing Severe Chronic Neutropenia Sequelae

Based on regulatory and peer-reviewed sources, the most extensive and long-term research available for a component of Imumax relates to Filgrastim, the specialized recombinant protein. This component was studied for use in people with specific blood disorders, known as severe chronic neutropenia, which is a condition characterized by functional limitations in the immune system. The research base includes initial, short-term randomized trials followed by large, longitudinal observational studies conducted over several years.

These studies monitored outcomes related to blood functions, such as the levels of the Absolute Neutrophil Count (ANC), which plays a critical role in fighting infection. Long-term observational data show patterns related to sustained neutrophil counts in this specific patient population. However, the results apply only to the populations studied, and research exploring the component's action with the other natural and mineral ingredients is limited.


Evidence for Use in Symptomatic Discomfort and Acute Functional Strain

Research examining the combined botanical and mineral components, such as Echinacea, Zinc Picolinate, and Selenium, was evaluated in people experiencing conditions involving periods of heightened symptoms, specifically those related to general acute illness. The primary research structure consists of randomized, placebo-controlled clinical trials (RCTs) and systematic reviews.

These studies monitored patient-reported outcomes describing perceived discomfort, such as symptom severity scores and the overall duration of the acute episode. Some trials described patterns where the time patients reported resolution of symptoms varied compared to those receiving a placebo, though the findings were mixed across different studies. The evidence is limited by variations in botanical extracts and follow-up durations were limited, typically lasting only for the short, acute phase. Therefore, long-term effects are not fully established.


Key Uncertainties and Research Gaps

A major gap in the current evidence landscape is the limited data available on the combined effect of all five active ingredients—Filgrastim, Bee Propolis, Echinacea, Selenium, and Zinc Picolinate—when used together in this specific formulation. The existing studies primarily evaluate the components either in isolation or in different combinations. Overall, research provides context but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Imumax (FAQ)

Q: How quickly should I expect to feel an effect after using Imumax?

Official information regarding the product’s specialized protein component, Filgrastim, indicates that a temporary increase in the Absolute Neutrophil Count (ANC) is typically observed within 1 to 2 days after starting therapy. Individual experiences regarding symptom improvement may vary.

Q: Is Imumax safe to use for kids under 12?

The safety and effectiveness of the full Imumax combination product have not been established in patients under 12 years of age. However, for specific medical conditions (neutropenia), use of the specialized protein component is established in pediatric patients 1 month of age and older. Eligibility for use in children is determined by a healthcare provider based on official criteria.

Q: Are there any common side effects people report with Imumax?

According to official regulatory sources, the most common side effects (Very Common, ge 1/10) include irritation and a burning sensation at the application or injection site. Common reactions (ge 1/100 to < 1/10) include headache, nasal dryness, and an alteration in taste.

Q: Can Imumax be used by people with asthma or other respiratory conditions?

Regulatory warnings indicate that serious adverse reactions, such as Acute Respiratory Distress Syndrome (ARDS), have been documented with the specialized protein component. Patients with pre-existing lung conditions, including asthma, should be monitored closely by their healthcare provider during therapy. It is important that a healthcare provider is aware of your full respiratory history before therapy is initiated.

Q: Can a pregnant woman safely use Imumax?

Official regulatory documents place restrictions on the use of Imumax during pregnancy. Use is generally advised only if the potential benefit justifies the potential risk to the fetus, as comprehensive data on systemic absorption in pregnant women may be limited. Any decision regarding use during pregnancy must be made in consultation with a treating physician.

Q: Can Imumax be used long-term, or should it only be used for a short time?

The administration for the specialized protein component is not continuous daily use, but is structured around defined treatment courses or cycles. The overall schedule is characterized by intermittent or cyclic administration. The duration of the treatment course is determined by the healthcare provider based on official product protocol.

Q: Is Imumax available over-the-counter or does it require a prescription?

The most potent component of Imumax is classified as a regulated biologic that requires administration under medical supervision, typically in a specialized clinical setting. Due to this requirement, the product is not available for purchase over-the-counter.

Q: Does Imumax help with nasal congestion or just fight the virus?

The general purpose of Imumax is to provide Comprehensive Immune Support and Cellular Protection by stimulating the production of white blood cells. It is not listed as a treatment for nasal congestion. In fact, nasal dryness is listed as a common side effect.

Q: Can you take Imumax if you're already taking a multivitamin?

The oral component, which contains Zinc Picolinate, requires separation from certain substances to avoid interference with absorption. Official guidance suggests informing a healthcare provider about all supplements, including multivitamins, as high doses of other minerals or vitamins may need to be timed separately from Imumax's oral component.

Q: Does Imumax have any known interactions with common pain relievers like paracetamol?

While paracetamol (acetaminophen) is not formally listed in the primary interaction classes, it is often used to manage common side effects like bone pain associated with Filgrastim. It is important that a healthcare provider is aware of any paracetamol use, as it can potentially mask a fever, which is an important sign of infection during treatment.

Q: How long does the effect of one dose of Imumax usually last?

The duration of effect is tied to the prescribed treatment cycle and the time it takes for your Absolute Neutrophil Count (ANC) to reach a specified target level. Dosing often continues daily until this clinical target is met, rather than for a fixed duration of time per single dose.

Q: Is it normal to feel a slight stinging or tingling when first using Imumax?

Yes, some common feelings at the injection site are documented. Official information classifies application site irritation and a burning sensation as Very Common side effects (ge 1/10).

Q: Are there any foods or drinks that should be avoided while using Imumax?

The oral component, which contains Zinc Picolinate, must be separated by at least two hours from the consumption of Milk/Dairy Products and High Fiber Foods. This separation is required to avoid impaired absorption of the Zinc. These items do not need to be strictly avoided entirely, only timed apart from the oral medication.

Q: Does Imumax interact with herbal supplements like Echinacea?

Echinacea is one of the active components of the Imumax formulation itself. The official label does not provide specific interaction data for using Imumax with other herbal supplements. A healthcare provider must be informed of all herbal products being taken.

Q: Why do some people use Imumax for a sore throat, even if it's a nasal spray?

The official product information defines Imumax's primary forms as an Injectable Solution (for the biologic component) and Oral Preparations (for the supportive components). Use as a nasal spray or for treating a sore throat directly is inconsistent with the official regulatory description of the product and its administration routes.

Q: Is it normal for the spray mechanism to get clogged sometimes?

This question is based on the incorrect assumption that the main product is a spray. The most potent component is an Injectable Solution which is administered using a syringe and needle. The oral components are capsules or liquid and do not involve a spray mechanism.

Q: Does using Imumax affect the sense of taste or smell?

Official information documents taste alteration as a Common side effect. Effects on the sense of smell are not specifically listed in the adverse reaction profile.

Q: Can I use Imumax at the same time as my regular allergy medication?

Regulatory documents require caution when co-administering Imumax with certain other drugs, especially those metabolized by specific liver enzymes (CYP3A4 and CYP1A2). It is necessary to confirm all co-administered therapies with a healthcare provider.

Q: What happens if I miss a scheduled dose of Imumax?

If a patient misses an injection or administers too little, official guidance states that a doctor or pharmacist should be contacted as soon as possible. The patient should not attempt to take a double dose to make up for a missed one.

Q: Does Imumax work for all types of viruses?

Imumax's mechanism is to stimulate white blood cell production, belonging to the class of hematopoietic growth factors, for comprehensive immune support and systemic cellular protection. It is not designed to directly target all types of viruses; its purpose is to boost the body's generalized defense mechanisms.

Q: Is it safe to use Imumax just before going to bed?

Regulatory information does not specify a restriction on the time of day for general use. The specialized component is given by injection. However, if the patient is also receiving chemotherapy, there are mandatory time separations required between the treatments.

Q: Can I use Imumax if I have sensitive nasal passages?

The primary biologic component of the product is an Injectable Solution, not a nasal spray. While nasal dryness is a common side effect of one of the components, the medicine's main administration is not via the nasal passages.

Q: What is the shelf life of Imumax after the bottle has been opened?

The injectable solution has strict handling requirements. If the product is removed from the refrigerator and kept at room temperature (20°C to 25°C), it must be discarded after a single period of 24 hours. Used vials and syringes are typically for single use and any remaining drug should be discarded.

Q: Does Imumax cause drowsiness or affect ability to drive?

Adverse reactions such as dizziness or feeling faint are listed in official product labeling. If a patient experiences these types of symptoms, it is advised to use caution when performing activities that require alertness, such as driving or operating machinery.

Q: Is Imumax effective against the common cold?

Research on the natural and mineral components was evaluated in people experiencing general acute illness and heightened symptoms. However, effectiveness against the specific common cold virus is not explicitly listed as a registered use for the total formulation.

Q: Are the claims about Imumax supported by independent research?

The official overview of studies refers to support from regulatory sources, peer-reviewed sources, Randomized, Placebo-Controlled Clinical Trials (RCTs), and long-term longitudinal observational studies. This includes data supporting the action of the individual components.

Q: What if the Imumax spray doesn't seem to be coming out correctly?

This question is based on the incorrect assumption that the main component is a spray. The most potent component is an Injectable Solution, which requires administration by a healthcare professional or trained user, with specific checks for the liquid solution before injection.

Q: Does Imumax contain any ingredients derived from animals?

Yes, the formulation is a combination product that includes Bee Propolis, which is a natural extract derived from bees. The other components are a recombinant human protein and essential minerals.

Q: Can I share my Imumax bottle with someone else?

No, the product is intended for individual patient use. Used syringes and needles are for single use only. To prevent contamination and infection, and due to the specialized nature of the medicine, multiple-dose containers (if applicable) and oral components should not be shared between patients.

Q: Why is it important to clean the nozzle of Imumax after use?

This question is based on the incorrect assumption of a spray. The Injectable Solution requires adherence to sterile handling and preparation protocols for the syringe and vial. Cleaning of any components is part of the required sterile procedure to preserve product integrity and prevent contamination.

Q: What if my child accidentally uses the spray more often than recommended?

If a dose larger than prescribed is administered, a healthcare professional should be contacted as soon as possible for guidance. The product is not administered via a spray mechanism.

Q: Is there a maximum number of days I should use Imumax consecutively?

The product is generally administered daily for a specified period, typically up to two weeks, or until the Absolute Neutrophil Count (ANC) reaches a required target level following a course of chemotherapy. The physician will define the maximum number of consecutive days for the patient’s specific treatment cycle.

How should Imumax be stored and disposed of?

How to Store and Dispose of Imumax

The storage requirements for the Imumax injectable solution are strictly governed by the constraints necessary to maintain the stability of the Filgrastim component.

Storage Requirements

  • Temperature: The medicine must be stored in a refrigerator at temperatures between 2°C and 8°C (36°F and 46°F). It must not be frozen.
  • Protection: Keep the product in its original carton to protect the solution from light.
  • Handling: The solution must not be shaken. If the product is kept at room temperature (20°C to 25°C), it must be discarded after a single period of 24 hours.
  • Safety: Store the medication out of the sight and reach of children.

Disposal Instructions

Used syringes and needles, which are for single use only, must not be thrown into household trash. They should be immediately placed into an FDA-cleared sharps disposal container. Disposal of the full sharps container must be completed according to the instructions provided by a healthcare provider or local authority guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Imumax found in:

A-Z Index: